Showing results (41-50 of 78) with videos related to

Sort By:
Pageof 8
Biomaterials|June 14, 2005
Selective targeting of antibody-conjugated nanoparticles to leukemic cells and primary T-lymphocytesNorbert Dinauer, Sabine Balthasar, Carolin Weber, et al.
Bioorganic & Medicinal Chemistry Letters|June 14, 2023
Synthesis, activity, metabolic stability and cell permeability of new cytosolic phospholipase A<sub>2</sub>α inhibitors with 1-indolyl-3-phenoxypropan-2-one structureAngelina Subeska, Merlin Ekodo Voundi, Walburga Hanekamp, et al.
Biomaterials|December 9, 2004
Preparation and characterisation of antibody modified gelatin nanoparticles as drug carrier system for uptake in lymphocytesSabine Balthasar, Kerstin Michaelis, Norbert Dinauer, et al.
RSC Advances|November 8, 2024
Self-immolative polydisulfides and their use as nanoparticles for drug delivery systemsKatharina Völlmecke, Maurice Kramer, Corinna Horky, et al.
International Journal of Pharmaceutics|May 4, 2019
In vitro evaluation of innovative light-responsive nanoparticles for controlled drug release in intestinal PDTLaura Mahlert, Juliane Anderski, Timo Schoppa, et al.
Anti-Cancer Drugs|March 20, 2002
Coupling of the antitumoral enzyme bovine seminal ribonuclease to polyethylene glycol chains increases its systemic efficacy in miceMartin Michaelis, Jindrich Cinatl, Jaroslav Cinatl, et al.
Neoplasia (New York, N.Y.)|March 6, 2008
Downregulation of Plk1 expression by receptor-mediated uptake of antisense oligonucleotide-loaded nanoparticlesBirgit Spänkuch, Isabel Steinhauser, Heidrun Wartlick, et al.
Biomacromolecules|November 16, 2018
Use of Light-Degradable Aliphatic Polycarbonate Nanoparticles As Drug Carrier for PhotosensitizerJingjiang Sun, Wolfgang Birnbaum, Juliane Anderski, et al.
Beilstein Journal of Nanotechnology|November 16, 2019
Incorporation of doxorubicin in different polymer nanoparticles and their anticancer activitySebastian Pieper, Hannah Onafuye, Dennis Mulac, et al.
Beilstein Journal of Nanotechnology|September 11, 2019
Doxorubicin-loaded human serum albumin nanoparticles overcome transporter-mediated drug resistance in drug-adapted cancer cellsHannah Onafuye, Sebastian Pieper, Dennis Mulac, et al.
Pageof 8